Amyloid Cardiomyopathy, Transthyretin-Related
4 clinical trials · Condition
◉ Watch Amyloid Cardiomyopathy, Transthyretin-Related
| Record | Firm | Date |
|---|---|---|
| Open-Label Safety Study of Acoramidis (AG10) in Symptomatic ATTR Participants (NCT04988386) | Eidos Therapeutics, a BridgeBio company | 2021-10-27 |
| Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations (NCT03812172) | Mathew S. Maurer, MD | 2019-05-15 |
| Single and Multiple Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of AG10 (NCT03294707) | Eidos Therapeutics, a BridgeBio company | 2017-09-11 |
Track Amyloid Cardiomyopathy, Transthyretin-Related automatically
Every clearance here is in the API, with alerts when new ones post.